Spondylarthritis may be associated with substantial burden of comorbidities, which can increase the cardiovascular risk. Obesity if associated with spondylarthritis not only can rise the risk of a possible heart disease but it may also deteriorate their functional prognosis.
The main target of this study was to evaluate the frequency of obesity in spondylarthritis patients.
We performed a cross-sectional study including 96 patients with spondylarthritis(SA) diagnosed according to ASAS criteria, the disease activity were assessed using ASDAS, for each patient we mesured height in meter and weight in kg and we calculated the body mass index(BMI) using the metric formula Weight(kg)/Height(m)2.
The mean average was 41.45 + 12.52 years, sex ratio was 3. Clinical phenotypes of SA were: ankylosing spondylarthritis (62.4%), psoriatic arthritis(20.8%), arthritis associated with inflammatory bowel disease (12%). The mean duration of the disease was 110.9 + 106.16 months. The mean C-reactive protein and erythrocyte sedimentation rate were 31.48 and 37.19 respectively. The mean ASDAS-CRP, BASMI and BASFI were 3.63 + 2.26 and 2.45 + 2.44, 4.61 + 2.67. The mean BMI was 25.38 + 4.61.Underweight percentage was 0.2%, patients in the normal range were 50%, patients with overweight percentage was 45.8%(33.33% were pre-obese and 14.58 % obese).54.34 % of patients with overweight have ankylosing spondylarthritis and 26% of them have psoriatic arthritis. There were no correlation between BMI and ASDAS-CRP, BASMI and BASFI.
Spondylarthritis with obesity may increase mortality in our population by increasing the cardiovascular risk, that is why a healthy eating and if possible a regular physical activity may improve the prognosis of the disease.
22 May 2021 - 26 May 2021